Keywords: Ulcerative Colitis; 5-Aminosalicylate; Corticosteroid; Thiopurine; Anti-Tumor Necrosis Factor; Vedolizumab; Probiotics; ADA; antidrug antibodies; CAG; Canadian Association of Gastroenterology; CI; confidence interval; FMT; fecal microbial transplant; GR
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Methylene blue MMX® tablets for chromoendoscopy. Bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy
Keywords: Methylene blue; Pharmacokinetics; Healthy subjects; MMX; Chromoendoscopy;
Mission analysis for the Martian Moons Explorer (MMX) mission
Keywords: MMX; Mars Phobos Deimos; Sample return mission; JAXA;
Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
Keywords: Plant-made vaccines; Plant-specific glycans; Allergy; Influenza A virus; Humoral response; IgG; IgE; CCDs; Cross-reactive carbohydrate determinants; Bromelain assay; CCD; cross-reactive carbohydrate determinants; HA; hemagglutinin; IgG/E; immunoglobulin G
Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Keywords: MMX; Biomarker; 5 Aminosalicylate; 5-ASA; Natural History; DEAR; Dose Escalation and Remission; FC; fecal calprotectin; IQR; interquartile range; MMX; multimatrix; RCT; randomized controlled trial; UC; ulcerative colitis;
Methylene blue MMX® tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers
Keywords: Methylene blue; Pharmacokinetics; Healthy subjects; MMX; Chromoendoscopy
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
Keywords: Inflammatory Bowel Disease; Clinical Trial Result; Inflammation; Colon; AE; adverse event; CI; confidence interval; ITT; intention-to-treat; MMX; multi-matrix system; OR; odds ratio; UCDAI; Ulcerative Colitis Disease Activity Index;
A multi-streaming SIMD multimedia computing engine
Keywords: SIMD; Multimedia processing; PIM; Processor-In-Memory; Multimedia extensions; MMX
Theoretical studies on electronic structures and magnetic interactions of K4[Pt2(pop)4X] · 2H2O (X = Cl, Br) complexes
Keywords: MMX; K4[Pt2(pop)4X] · 2H2O (X = Cl, Br); Magnetic interaction; Effective exchange integrals (J); DFT calculation
Controversies in Ulcerative Colitis: A Survey Comparing Decision Making of Experts Versus Community Gastroenterologists
Keywords: CSA; cyclosporine; CT; computed tomography; DI; disagreement index; LGD; low-grade dysplasia; MMX; multi-matrix system; MR; magnetic resonance; NBI; narrow band imaging; RAS; RAND appropriateness scale;
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?
Keywords: Ulcerative colitis; Therapy; 5-Aminosalicylate; Mesalazine; MMX; Once daily; Compliance
Affinity of IgE and IgG against cross-reactive carbohydrate determinants on plant and insect glycoproteins
Keywords: CCDs; carbohydrate determinant; binding affinity; glycoprotein; CCD; Cross-reactive carbohydrate determinant; GlcNAc; N-acetylglucosamineâ; HRP; Horseradish peroxidase; MM; Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc; MMF3 (MMF); Manα1-6(Manα1-3)Manβ
Theoretical studies on relation among structures, electric structures and magnetic interactions in MMX complexes
Keywords: MMX; Magnetic interaction; Effective exchange integral (Jab); Density functional theory (DFT) calculation; Potential surface
Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis
Keywords: AE; adverse event; CI; confidence interval; GCP; good clinical practices; ITT; intent to treat; MMX; Multi Matrix System; OR; odds ratio; PGA; Physician's Global Assessment; PP; per protocol; SAE; serious adverse event; UC; ulcerative colitis; UC-DAI; u